Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  The Lancet

• Publication date

  2005-04-09

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/S0140-6736(05)61029-XPMID 15823382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of flies and provision of latrines in trachoma control: cluster-randomised controlled trial.

  2004cited by this paper
• Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas?

  2003cited by this paper
• Antibiotic dosage in trachoma control programs: height as a surrogate for weight in children.

  2003cited by this paper
• Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages.

  2003cited by this paper
• Strategies for control of trachoma: observational study with quantitative PCR.

  2003cited by this paper
• Essential Medical Statistics

  2003cited by this paper
• OmpA genotypic evidence for persistent ocular Chlamydia trachomatis infection in Tanzanian village women

  2001cited by this paper
• Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma.

  2001cited by this paper
• Cross-sectional survey of trachoma in school age children in the region of Thiès (Senegal)

  2000cited by this paper
• Review of the evidence base for the ‘F’ and ‘E’ components of the SAFE strategy for trachoma control

  2000cited by this paper
• Effect of fly control on trachoma and diarrhoea.

  1999cited by this paper
• Azithromycin for control of trachoma.

  1999cited by this paper
• Azithromycin in control of trachoma.

  1999cited by this paper
• Reliability of clinical diagnosis in identifying infectious trachoma in a low-prevalence area of Nepal.

  1999cited by this paper
• The duration of human ocular Chlamydia trachomatis infection is age dependent

  1999cited by this paper
• Global elimination of trachoma: How frequently should we administer mass chemotherapy?

  1999cited by this paper
• Trachoma in the Gambia

  1998cited by this paper
• Impact of face-washing on trachoma in Kongwa, Tanzania.

  1995cited by this paper
• Global data on blindness.

  1995cited by this paper
• Randomised controlled trial of single-dose azithromycin in treatment of trachoma.

  1993cited by this paper
• Nonocular Chlamydia infection and risk of ocular reinfection after mass treatment in a trachoma hyperendemic area.

  1993cited by this paper
• Persisting inapparent chlamydial infection in a trachoma endemic community in The Gambia.

  1990cited by this paper
• A simple system for the assessment of trachoma and its complications.

  1987cited by this paper

• Monitoring of Chlamydia trachomatis infection and antibodies in low-prevalence districts of Amhara, Ethiopia: Insights from a hyper-endemic trachoma region.

  2026cites this paper
• Association between presence of latrine and unclean child face on the prevalence of active trachoma among children aged 1 to 9 years in low-income setting: A systematic review and meta-analysis

  2025cites this paper
• Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG

  2024cites this paper
• Photographic grading to evaluate facial cleanliness and trachoma among children in Amhara region, Ethiopia

  2024cites this paper
• Determination of the safety and efficacy of recombinant Chlamydia muridarum MOMP vaccines, formulated with CpG-1826 and 70%, 50%, 30% or 10% concentrations of Montanide ISA-720 VG, to elicit protective immune responses against a C. muridarum respiratory challenge

  2023cites this paper
• Trachoma risk factors in Oromia Region, Ethiopia

  2023cites this paper
• Targeted mass azithromycin distribution for trachoma: a community-randomized trial (TANA II).

  2023cites this paper
• Risk of seroconversion and seroreversion of antibodies to Chlamydia trachomatis pgp3 in a longitudinal cohort of children in a low trachoma prevalence district in Tanzania

  2022cites this paper
• When the Neighboring Village is Not Treated: Role of Geographic Proximity to Communities Not Receiving Mass Antibiotics for Trachoma.

  2022cites this paper
• Stopping azithromycin mass drug administration for trachoma: A systematic review

  2021cites this paper
• Serology, infection, and clinical trachoma as tools in prevalence surveys for re-emergence of trachoma in a formerly hyperendemic district

  2021cites this paper
• Targeted antibiotics for trachoma: a cluster-randomized trial.

  2021cites this paper
• Effectiveness of azithromycin mass drug administration on trachoma: a systematic review

  2021influential citation
• Mathematical Modelling for the Transmission Dynamics of blinding Trachoma

  2021cites this paper
• Ocular Chlamydia trachomatis infection and infectious load among pre-school aged children within trachoma hyperendemic districts receiving the SAFE strategy, Amhara region, Ethiopia

  2020cites this paper
• Understanding hard-to-reach communities: local perspectives and experiences of trachoma control among the pastoralist Maasai in northern Tanzania

  2020cites this paper
• Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The

  2020cites this paper
• Induction of protection in mice against a respiratory challenge by a vaccine formulated with exosomes isolated from Chlamydia muridarum infected cells

  2020cites this paper
• Effectiveness and safety of azithromycin 1.5% eye drops for mass treatment of active trachoma in a highly endemic district in Cameroon

  2020cites this paper
• Ocular Chlamydia trachomatis infection: elimination with mass drug administration

  2019cites this paper
• Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community

  2019cites this paper
• Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal

  2019cites this paper
• Studies on the Development of Scarring Trachoma in Tanzania

  2019cites this paper
• Prevalence of Follicular Trachoma and Trichiasis in The Gambia: Has Elimination

  2018cites this paper
• A Cluster-Randomized Trial to Assess the Efficacy of Targeting Trachoma Treatment to Children

  2018cites this paper
• Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia

  2018cites this paper
• The distribution of district-level leprosy incidence in India is geometric-stable, consistent with subcriticality.

  2018cites this paper
• A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution

  2018cites this paper
• Population-based prevalence survey of follicular trachoma and trachomatous trichiasis in the Casamance region of Senegal

  2017influential citation
• Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies

  2017cites this paper
• Chlamydial eye infections: Current perspectives

  2017cites this paper
• Treating village newcomers and travelers for trachoma: Results from ASANTE cluster randomized trial

  2017cites this paper
• The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa

  2017influential citation
• Trachoma as cause of blindness: literature review

  2017cites this paper
• Using alternate indicators to define need for publichealth intervention for trachoma: Evidence from the Pacific Islands

  2017cites this paper
• 112 – Eye Infections in the Tropics

  2017cites this paper
• Diseases in Africa: An Overview

  2017cites this paper
• Surveillance Surveys for Reemergent Trachoma in Formerly Endemic Districts in Nepal From 2 to 10 Years After Mass Drug Administration Cessation

  2017cites this paper
• Tracking Trachoma: How The Gambia Is Eliminating an Ancient Disease

  2017cites this paper
• Prospects for trachoma elimination through mass treatment targeted at children

  2016cites this paper
• Enhanced antibiotic distribution strategies and the potential impact of facial cleanliness and environmental improvements for the sustained control of trachoma: a modelling study

  2016cites this paper
• Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program

  2016cites this paper
• Blinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive Disease

  2016cites this paper
• A Cluster-Randomized Trial to Assess the Efficacy of Targeting Trachoma Treatment to Children

  2016cites this paper
• The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment

  2016cites this paper
• Cross-Sectional Surveys of the Prevalence of Follicular Trachoma and Trichiasis in The Gambia: Has Elimination Been Reached?

  2016cites this paper
• Mathematical Modelling of Trachoma Transmission, Control and Elimination.

  2016cites this paper
• Trachoma and Relative Poverty: A Case-Control Study

  2015cites this paper
• Serology for Trachoma Surveillance after Cessation of Mass Drug Administration

  2015cites this paper
• The Allee effect and elimination of neglected tropical diseases: a mathematical modelling study.

  2015cites this paper
• Estimating the Future Impact of a Multi-Pronged Intervention Strategy on Ocular Disease Sequelae Caused by Trachoma: A Modeling Study

  2015cites this paper
• MICROBIOLOGICAL CONFIRMATION OF A FOCUS OF ACTIVE TRACHOMA IN AMERINDIANS OF COLOMBIA, SOUTH AMERICA

  2015cites this paper
• Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control

  2015cites this paper
• Costs of Testing for Ocular Chlamydia trachomatis Infection Compared to Mass Drug Administration for Trachoma in The Gambia: Application of Results from the PRET Study

  2015influential citation
• Possible changes in the transmissibility of trachoma following MDA and transmission reduction: implications for the GET2020 goals

  2015cites this paper
• Serological Measures of Trachoma Transmission Intensity

  2015cites this paper
• Risk Factors for Active Trachoma and Ocular Chlamydia trachomatis Infection in Treatment-Naïve Trachoma-Hyperendemic Communities of the Bijagós Archipelago, Guinea Bissau

  2014cites this paper
• Enhancement of Lateral Flow Assay for the Detection of Whole Viral Particle and Chlamydial Elementary Bodies

  2014cites this paper
• Trachoma.

  2014cites this paper
• Non-Participation during Azithromycin Mass Treatment for Trachoma in The Gambia: Heterogeneity and Risk Factors

  2014cites this paper
• Effect of Water, Sanitation, and Hygiene on the Prevention of Trachoma: A Systematic Review and Meta-Analysis

  2014cites this paper
• Molecular Diagnosis of Ocular Infections

  2014cites this paper
• Mass administration of azithromycin and Streptococcus pneumoniae carriage: cross-sectional surveys in the Gambia.

  2014cites this paper
• Geospatial distribution and clustering of Chlamydia trachomatis in communities undergoing mass azithromycin treatment.

  2014cites this paper
• Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma?: PRET Ziada trial results.

  2013cites this paper
• Short Report: The Association between Latrine Use and Trachoma: A Secondary Cohort Analysis from a Randomized Clinical Trial

  2013cites this paper
• The association between latrine use and trachoma: a secondary cohort analysis from a randomized clinical trial.

  2013cites this paper
• Development and Evaluation of a Next-Generation Digital PCR Diagnostic Assay for Ocular Chlamydia trachomatis Infections

  2013cites this paper
• Using a Nonparametric Multilevel Latent Markov Model to Evaluate Diagnostics for Trachoma

  2013cites this paper
• Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia

  2013cites this paper
• Follicular trachoma and trichiasis prevalence in an urban community in The Gambia, West Africa: is there a need to include urban areas in national trachoma surveillance?

  2013cites this paper
• A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma

  2013cites this paper
• Trachoma and Inclusion Conjunctivitis

  2013cites this paper
• Active trachoma is an infectious disease, stop treating it administratively

  2013cites this paper
• PUBLIC HEALTH AND THE EYE

  2012cites this paper
• Trachoma and antibiotic use: the ’A‘ in SAFE

  2012cites this paper
• The “segment knockout” survey method for large trachoma-endemic districts

  2012cites this paper
• Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial.

  2012cites this paper
• Trachoma: an update on prevention, diagnosis, and treatment

  2012cites this paper
• Inhibitory effects of 405 nm irradiation on Chlamydia trachomatis growth and characterization of the ensuing inflammatory response in HeLa cells

  2012cites this paper
• Assuring the Safety and Effectiveness of New Drugs: Rigorous Phase IV Trials Randomizing General Practices to Delayed Access to New Drugs

  2012cites this paper
• Social and environmental risk factors for trachoma: a mixed methods approach in the Kembata Zone of southern Ethiopia

  2011cites this paper
• Risk Factors for Ocular Chlamydia after Three Mass Azithromycin Distributions

  2011influential citation
• Risk Factors for Ocular Infection with Chlamydia trachomatis in Children 6 Months following Mass Treatment in Tanzania

  2011cites this paper
• Number of Years of Annual Mass Treatment With Azithromycin Needed to Control Trachoma in Hyper-endemic Communities in Tanzania

  2011cites this paper
• Can clinical signs of trachoma be used after multiple rounds of mass antibiotic treatment to indicate infection?

  2011cites this paper
• Efficacy of latrine promotion on emergence of infection with ocular Chlamydia trachomatis after mass antibiotic treatment: a cluster-randomized trial.

  2011cites this paper
• Design and Baseline Data of a Randomized Trial to Evaluate Coverage and Frequency of Mass Treatment with Azithromycin: The Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia

  2011cites this paper
• Modelling parasite transmission and control

  2010cites this paper
• Travel and Implications for the Elimination of Trachoma in Ethiopia

  2010cites this paper
• Epidemiology and control of trachoma: systematic review

  2010influential citation
• Transmission dynamics and control of trachoma

  2010cites this paper
• Profound and Sustained Reduction in Chlamydia trachomatis in The Gambia: A Five-Year Longitudinal Study of Trachoma Endemic Communities

  2010cites this paper
• Modelling trachoma for control programmes.

  2010cites this paper
• Effect of oral azithromycin in the treatment of chlamydial conjunctivitis

  2010cites this paper
• Modelling Trachoma for Control

  2010cites this paper
• Phylogenetic Analysis of Chlamydia trachomatis Tarp and Correlation with Clinical Phenotype

  2010cites this paper
• Bio-Medico di Roma Corso di dottorato di ricerca in IMMUNOLOGIA OCULARE XXII ciclo anno 2007 Avoidable Blindness : Development and Implementation of Surveillance System for Trachoma in Post-Endemic Countries

  2010cites this paper
• The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control

  2009cites this paper
• Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.

  2009cites this paper